Literature DB >> 33603667

Qu-Zhuo-Tong-Bi Decoction Alleviates Gouty Arthritis by Regulating Butyrate-Producing Bacteria in Mice.

Xianghui Wen1, Yu Lou1, Siyue Song1, Zhixing He1, Juan Chen1, Zhijun Xie1, Xiaowei Shi1, Chengping Wen1, Tiejuan Shao1.   

Abstract

Qu-zhuo-tong-bi decoction (QZTBD) is a traditional Chinese medicine prescription used to treat hyperuricemia and gout with no obvious adverse effects. However, the mechanism by which QZTBD treats gout has not been fully explored. Here, we investigated the effects of QZTBD on gouty arthritis and its therapeutic mechanism from the perspective of the gut microbiome. Our results demonstrated that QZTBD was effective for reducing serum uric acid level and attenuating paw edema and mechanical allodynia. QZTBD promoted the abundance of butyrate-producing bacteria and the production of SCFAs. Further study revealed that QZTBD restored the intestinal barrier function, modulated the expression of GPR43 and ABCG2, suppressed the activity of key glycolysis-related enzymes, and inhibited the generation of intestinal inflammatory factors. These findings suggested that QZTBD is an effective therapeutic drug for gouty arthritis. Butyrate-producing bacteria and its metabolites SCFAs might act as a potential target of QZTBD.
Copyright © 2021 Wen, Lou, Song, He, Chen, Xie, Shi, Wen and Shao.

Entities:  

Keywords:  Qu-zhuo-tong-bi decoction; SCFAs; gouty arthritis; gut homeostasis; gut microbiota

Year:  2021        PMID: 33603667      PMCID: PMC7884811          DOI: 10.3389/fphar.2020.610556

Source DB:  PubMed          Journal:  Front Pharmacol        ISSN: 1663-9812            Impact factor:   5.810


  27 in total

Review 1.  Global epidemiology of gout: prevalence, incidence and risk factors.

Authors:  Chang-Fu Kuo; Matthew J Grainge; Weiya Zhang; Michael Doherty
Journal:  Nat Rev Rheumatol       Date:  2015-07-07       Impact factor: 20.543

2.  Editorial: Can GPR43 Sensing of Short-Chain Fatty Acids Unchain Inflammasome-Driven Arthritis?

Authors:  Alexander Haslberger; Robert Terkeltaub
Journal:  Arthritis Rheumatol       Date:  2015-06       Impact factor: 10.995

3.  Dietary fiber and the short-chain fatty acid acetate promote resolution of neutrophilic inflammation in a model of gout in mice.

Authors:  Angélica T Vieira; Izabela Galvão; Laurence M Macia; Érica M Sernaglia; Marco Aurélio R Vinolo; Cristiana C Garcia; Luciana P Tavares; Flávio A Amaral; Lirlândia P Sousa; Flaviano S Martins; Charles R Mackay; Mauro M Teixeira
Journal:  J Leukoc Biol       Date:  2016-08-05       Impact factor: 4.962

4.  Heterogeneity-disease relationship in the human microbiome-associated diseases.

Authors:  Zhanshan Sam Ma
Journal:  FEMS Microbiol Ecol       Date:  2020-07-01       Impact factor: 4.194

Review 5.  The gut-bone axis: how bacterial metabolites bridge the distance.

Authors:  Mario M Zaiss; Rheinallt M Jones; Georg Schett; Roberto Pacifici
Journal:  J Clin Invest       Date:  2019-07-15       Impact factor: 14.808

6.  Effect of a traditional Chinese medicine prescription Quzhuotongbi decoction on hyperuricemia model rats studied by using serum metabolomics based on gas chromatography-mass spectrometry.

Authors:  Jiao Chen; Jia Zhou; Shuangshuang Wei; Zhijun Xie; Chengping Wen; Guowang Xu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2015-11-21       Impact factor: 3.205

7.  Decreased extra-renal urate excretion is a common cause of hyperuricemia.

Authors:  Kimiyoshi Ichida; Hirotaka Matsuo; Tappei Takada; Akiyoshi Nakayama; Keizo Murakami; Toru Shimizu; Yoshihide Yamanashi; Hiroshi Kasuga; Hiroshi Nakashima; Takahiro Nakamura; Yuzo Takada; Yusuke Kawamura; Hiroki Inoue; Chisa Okada; Yoshitaka Utsumi; Yuki Ikebuchi; Kousei Ito; Makiko Nakamura; Yoshihiko Shinohara; Makoto Hosoyamada; Yutaka Sakurai; Nariyoshi Shinomiya; Tatsuo Hosoya; Hiroshi Suzuki
Journal:  Nat Commun       Date:  2012-04-03       Impact factor: 14.919

8.  Intestinal Microbiota Distinguish Gout Patients from Healthy Humans.

Authors:  Zhuang Guo; Jiachao Zhang; Zhanli Wang; Kay Ying Ang; Shi Huang; Qiangchuan Hou; Xiaoquan Su; Jianmin Qiao; Yi Zheng; Lifeng Wang; Eileen Koh; Ho Danliang; Jian Xu; Yuan Kun Lee; Heping Zhang
Journal:  Sci Rep       Date:  2016-02-08       Impact factor: 4.379

9.  Intestinal Inflammation Modulates the Epithelial Response to Butyrate in Patients With Inflammatory Bowel Disease.

Authors:  Elena Ferrer-Picón; Isabella Dotti; Ana M Corraliza; Aida Mayorgas; Miriam Esteller; José Carlos Perales; Elena Ricart; Maria C Masamunt; Anna Carrasco; Eva Tristán; Maria Esteve; Azucena Salas
Journal:  Inflamm Bowel Dis       Date:  2020-01-01       Impact factor: 5.325

10.  A critical time window for the analgesic effect of central histamine in the partial sciatic ligation model of neuropathic pain.

Authors:  Jie Yu; Ying-Ying Tang; Ran-Ran Wang; Guo-Dong Lou; Ting-Ting Hu; Wei-Wei Hou; Jia-Xing Yue; Hiroshi Ohtsu; Li-Yun Shi; Shi-Hong Zhang; Zhong Chen
Journal:  J Neuroinflammation       Date:  2016-06-24       Impact factor: 8.322

View more
  7 in total

1.  Cynarin suppresses gouty arthritis induced by monosodium urate crystals.

Authors:  Changgui Wu; Shaohua Chen; Yang Liu; Bo Kong; Wei Yan; Tao Jiang; Hao Tian; Zhaoyi Liu; Qi Shi; Yongjun Wang; Qianqian Liang; Xiaobing Xi; Hao Xu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

2.  Effects of β-Carotin and Green Tea Powder Diets on Alleviating the Symptoms of Gouty Arthritis and Improving Gut Microbiota in C57BL/6 Mice.

Authors:  Yu Feng; Yanbo Yu; Zheng Chen; Lili Wang; Jingyu Ma; Xiaohui Bai; Yundong Sun; Dawei Wang
Journal:  Front Microbiol       Date:  2022-01-25       Impact factor: 5.640

3.  Alteration of Gut Microbiome and Correlated Amino Acid Metabolism Contribute to Hyperuricemia and Th17-Driven Inflammation in Uox-KO Mice.

Authors:  Siyue Song; Yu Lou; Yingying Mao; Xianghui Wen; Moqi Fan; Zhixing He; Yang Shen; Chengping Wen; Tiejuan Shao
Journal:  Front Immunol       Date:  2022-02-07       Impact factor: 7.561

4.  Treatment of gouty arthritis is associated with restoring the gut microbiota and promoting the production of short-chain fatty acids.

Authors:  Han-Ki Park; Sang Jin Lee
Journal:  Arthritis Res Ther       Date:  2022-02-19       Impact factor: 5.156

5.  Experimental Evidence of Buyang Huanwu Decoction and Related Modern Preparations (Naoxintong Capsule and Yangyin Tongnao Granule) in Treating Cerebral Ischemia: Intestinal Microorganisms and Transcriptomics in Rats.

Authors:  Junjun Yin; Jiehong Yang; Buchang Zhao; Chao Zhao; Wei Fu; Yu He; Miaolin Zeng; Yuting Yang; Xiaoyu Wei; Zhishan Ding; Jingxian Bai; Haitong Wan; Huifen Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-21       Impact factor: 2.650

6.  Mechanism Investigation of Wuwei Shexiang Pills on Gouty Arthritis via Network Pharmacology, Molecule Docking, and Pharmacological Verification.

Authors:  Jirui Lang; Li Li; Shilong Chen; Yunyun Quan; Jing Yi; Jin Zeng; Yong Li; Junning Zhao; Zhujun Yin
Journal:  Evid Based Complement Alternat Med       Date:  2022-10-07       Impact factor: 2.650

7.  Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus.

Authors:  Weifeng Zhang; Ting Wang; Ruixue Guo; Wen Cui; Wei Yu; Zhihui Wang; Yumin Jiang; Minghan Jiang; Xiaojie Wang; Chao Liu; Jing Xiao; Jin Shang; Xuejun Wen; Zhanzheng Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-01-18       Impact factor: 5.293

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.